Witte Jan De insider trades: Resmed (RMD) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Witte reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | RMD | ↓ Sell | 2,055 | $255.00 | $524K | Direct | Nov 26, 2025 (1d) |
| Nov 11, 2025 | RMD | ↓ Sell | 487 | $250.25 | $122K | Direct | Nov 13, 2025 (2d) |
| May 20, 2025 | RMD | ↓ Sell | 2,000 | $243.47 | $487K | Direct | May 22, 2025 (2d) |
| Nov 12, 2024 | RMD | ↓ Sell | 796 | $248.81 | $198K | Direct | Nov 14, 2024 (2d) |
| May 15, 2024 | RMD | ↓ Sell | 360 | $218.29 | $79K | Direct | May 17, 2024 (2d) |
| Jun 1, 2023 | IART | ↑ Buy | 7,792 | $38.50 | $300K | Direct | Jun 2, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RMD insiders
Open-market trades in the last 12 months
About Witte Jan De's insider trades
Witte Jan De is a director at Resmed (RMD). Since Jun 1, 2023, Witte has reported 1 open-market purchase worth $300K and 5 sales worth $1.4M on SEC Form 4. In the last 12 months: 2 sales ($646K).
Their filings also include grants and awards (13 filings), shares withheld for taxes (10 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.